AnaptysBio Inc Stock
AnaptysBio Inc Stock
AnaptysBio Inc dominated the market today, gaining €2.10 (12.070%).
With 7 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 19.5 € the target price of 45 € shows a potential of 130.77% for AnaptysBio Inc which would more than double the current price.
Pros and Cons of AnaptysBio Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of AnaptysBio Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
AnaptysBio Inc | 12.070% | 6.557% | -6.250% | 3.723% | 0.515% | -4.412% | - |
Immunic Inc. | 1.310% | -0.609% | -6.998% | -24.405% | -20.070% | -91.007% | - |
NanoViricides Inc. | -1.940% | 0.000% | -2.885% | -10.619% | 6.878% | -70.154% | -77.139% |
Ocuphire Pharma Inc. | 5.170% | 9.477% | -16.685% | -67.029% | -44.615% | - | - |
Comments
AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $47.00 price target on the stock.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio, Inc. (NASDAQ: ANAB) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $34.00 price target on the stock, up previously from $20.00.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at BTIG Research. They set a "buy" rating and a $55.00 price target on the stock.
Show more
Ratings data for ANAB provided by MarketBeat
News
Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week
Many stocks were wobbly over the past few trading days, but we can't say that about biotech AnaptysBio (NASDAQ: ANAB). The company's shares closed the week almost 8% higher in price, according to